Biogen Income Statement
BIIB / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$9.9B
FY2025
Gross Profit
N/A
FY2025
Operating Income
N/A
FY2025
Net Income
$1.3B
FY2025
Biogen reported $9.9B in revenue and $1.3B in net income for FY2025. Revenue has grown at a 4.9% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.9B | $9.7B | $9.8B | $10.2B | $11.0B | $13.4B | $14.4B | $13.5B | $12.3B | $11.4B | $10.8B | $9.7B | $6.9B | $5.5B | $5.0B |
| Cost of Revenue | $2.4B | $2.3B | $2.5B | $2.3B | $2.1B | $1.8B | $2.0B | $1.8B | $1.6B | $1.5B | $1.2B | $1.2B | $857.7M | $545.5M | $466.8M |
| Gross Profit | - | - | - | - | - | $11.6B | $12.4B | $11.6B | $10.6B | $10.0B | $9.5B | $8.5B | $6.1B | $5.0B | $4.6B |
| SG&A Expense | $2.4B | $2.4B | $2.5B | $2.4B | $2.7B | $2.5B | $2.4B | $2.1B | $1.9B | $1.9B | $2.1B | $2.2B | $1.7B | $1.3B | $1.1B |
| R&D Expense | $1.8B | $2.0B | $2.4B | $2.2B | $2.5B | $4.0B | $2.3B | $2.6B | $2.3B | $2.0B | $2.0B | $1.9B | $1.4B | $1.3B | $1.2B |
| Operating Income | - | - | - | - | $2.8B | $4.6B | $7.0B | $5.9B | $5.3B | $5.2B | $4.9B | $4.0B | $2.5B | $1.9B | $1.7B |
| Interest Expense | $267.5M | $250.3M | $246.9M | $246.6M | $253.6M | $222.5M | $187.4M | $200.6M | $250.8M | $260.0M | $95.5M | $29.5M | $31.9M | $36.5M | $33.0M |
| Income Tax | $263.6M | $273.8M | $135.3M | $632.8M | $52.5M | $992.3M | $1.2B | $1.4B | $2.5B | $1.2B | $1.2B | $989.9M | $601.0M | $470.6M | $444.5M |
| Net Income | $1.3B | $1.6B | $1.2B | $3.0B | $1.6B | $4.0B | $5.9B | $4.4B | $2.5B | $3.7B | $3.5B | $2.9B | $1.9B | $1.4B | $1.2B |
| EPS (Basic) | $8.02 | $20.96 | $10.44 | $24.86 | $31.47 | $21.63 | $11.94 | $16.96 | $15.38 | $12.42 | $7.86 | $5.80 | $5.09 | $3.98 | $3.37 |
| EPS (Diluted) | $7.97 | $20.87 | $10.40 | $24.80 | $31.42 | $21.58 | $11.92 | $16.93 | $15.34 | $12.37 | $7.81 | $5.76 | $5.04 | $3.94 | $3.35 |
| Shares Outstanding | 144.9M | 144.0M | 147.0M | 152.4M | 174.2M | 197.2M | 211.5M | 215.9M | 215.9M | 218.6M | 234.6M | 236.3M | 236.6M | 242.1M | 240.5M |
| Gross Margin | - | - | - | - | - | 86.6% | 86.4% | 86.5% | 86.7% | 87.1% | 88.5% | 87.9% | 87.6% | 90.1% | 90.8% |
| Operating Margin | - | - | - | - | 25.9% | 33.8% | 49.0% | 43.8% | 43.5% | 45.0% | 45.4% | 40.9% | 36.3% | 33.6% | 34.2% |
| Profit Margin | 13.1% | 16.9% | 11.8% | 29.9% | 14.2% | 29.8% | 41.0% | 32.9% | 20.7% | 32.3% | 33.0% | 30.3% | 26.9% | 25.0% | 24.4% |